Skip to main content

Vanguard Feline RC Intranasal

This page contains information on Vanguard Feline RC Intranasal for veterinary use.
The information provided typically includes the following:
  • Vanguard Feline RC Intranasal Indications
  • Warnings and cautions for Vanguard Feline RC Intranasal
  • Direction and dosage information for Vanguard Feline RC Intranasal

Vanguard Feline RC Intranasal

This treatment applies to the following species:
Company: Zoetis

Feline Rhinotracheitis-Calicivirus Vaccine

MODIFIED LIVE VIRUS

RC

MODIFIED LIVE VACCINE

NASAL

To Reconstitute:

Rehydrate the vaccine with the sterile diluent for vaccination.

FOR EASIER STORAGE & VIEWING

● Pull down on the tab.

● Flip tab out and set bottom tray of vials inside top lid.

This product has been shown to be effective for the vaccination of healthy cats 12 weeks of age or older against feline herpesvirus-1 and feline calicivirus. Duration of immunity has not been established. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.

Directions For Use

Aseptically rehydrate the freeze-dried vaccine with the sterile diluent provided. Shake well. Using sterile dropper, inoculate nasal passages with entire volume of vaccine. Alternatively, 1 drop of vaccine may be placed in each eye and the remainder placed into nasal passages. Administer vaccine within 30 minutes after rehydration. Healthy cats 12 weeks of age or older should receive one 0.5-mL dose. Cats vaccinated at less than 12 weeks of age should be revaccinated at 12 weeks of age. Historically, annual revaccination with this product was recommended. The need for annual booster vaccinations has not been established; consultation with a veterinarian or the manufacturer is recommended.

Warning

Transient sneezing may be observed 4-7 days after vaccination. Oral lesions may be observed postvaccinally, but typically heal without incident. Vaccination of cats incubating or harboring latent infections may result in more pronounced upper respiratory signs, ocular irritation, or febrile response.

Precautions

Store at 2°-8°C. Prolonged exposure to higher temperatures and/or direct sunlight may adversely affect potency. Do not freeze. Inactivate unused contents before disposal. Contains gentamicin as preservative. This product has not been tested in pregnant animals. As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy. Do not mix with other products, except as specified on the label. In case of human exposure, contact a physician.

Technical inquiries should be directed to Zoetis Inc. Veterinary Services, (888) 963-8471.

This product has been shown to be efficacious in healthy animals. A protective immune response may not be elicited if animals are incubating an infectious disease, are malnourished or parasitized, are stressed due to shipment or environmental conditions, are otherwise immunocompromised, or the vaccine is not administered in accordance with label directions.

VLN 190/PCN 16C1.20

Zoetis Inc., Kalamazoo, MI 49007, USA

25 Vials (1 dose)

STERILE DILUENT 25 Vials (0.5 mL)

40024580

CPN: 3690234.2

ZOETIS INC.
333 PORTAGE STREET, KALAMAZOO, MI, 49007
Telephone:   269-359-4414
Customer Service:   888-963-8471
Website:   www.zoetis.com
THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.

Copyright © 2022 Animalytix LLC. Updated: 2022-11-29